Kevin HARRINGTON | Institute of Cancer Research, London | Division of Radiotherapy and Imaging | Research profile
Professor Kevin Harrington - The Institute of Cancer Research, London
Kevin Harrington - Reader in Biological Cancer Therapies - Institute of Cancer Research | LinkedIn
SAB and I-O AB - T3 Pharma
Potential of immunotherapy in head and neck cancer | VJOncology
Royal Marsden researchers named among world's most influential scientists | The Royal Marsden
Game-changing drug doubles head and neck cancer survival | The Royal Marsden
T-VEC injections into melanoma lesions show significant response rate - ecancer
Potential of immunotherapy in head and neck cancer | VJOncology
Potential of immunotherapy in head and neck cancer | VJOncology
Will Immunotherapy Put Head and Neck Surgeons Out of Business? – Semon Lectures
Clinical results, patient cases and future developments II: Head & neck cancer – Kevin Harrington on Vimeo
Kevin HARRINGTON | Institute of Cancer Research, London | Division of Radiotherapy and Imaging | Research profile
Professor Kevin Harrington - The Institute of Cancer Research, London
Scientific Advisory Board – PsiVac
Scientific Lecture | Kevin Harrington | FRONTAL
ESMO Immuno-Oncology Congress 2022: Who should take part in this event? - YouTube
Longtime Fan Uses Ducks Hockey in His Cancer Fight
Professor Kevin Harrington | The Royal Marsden
Immunotherapy for recurrent or metastatic HNSCC: What are the practical considerations? - touchONCOLOGY
Prof. Kevin Harrington | HSTalks
Randomised trial of pembrolizumab versus standard treatment in patients with recurrent or metastatic head and neck cancer - ecancer
Professor Kevin Harrington - The Institute of Cancer Research, London
World's first centre for recurrent head and neck cancer launched - Professor Christopher Nutting Oncology
Professor Kevin Harrington - YouTube
